Sherman Asset Management’s Pfizer PFE Stock Holding History

Sherman Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.2K	Sell	3,497 -1,336	-28%	-$34.9K	0.07%	85
2026 Q1	$136K	Hold	4,833	–	–	0.12%	68
2025 Q4	$120K	Hold	4,833	–	–	0.1%	79
2025 Q3	$123K	Hold	4,833	–	–	0.11%	75
2025 Q2	$117K	Hold	4,833	–	–	0.1%	77
2025 Q1	$122K	Sell	4,833 -19	-0.4%	-$497	0.12%	78
2024 Q4	$129K	Buy	+4,852	New	+$132K	0.12%	76

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sherman Asset Management's PFE Position: Q2 2026 in Review

Sherman Asset Management reduced its Pfizer (PFE) stake by 28% in Q2 2026, selling an estimated $34.9K and leaving 3,497 shares worth $84.2K. The position accounts for 0.07% of the portfolio, ranked #85.

Sherman Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $136K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sherman Asset Management held 3,497 shares of Pfizer worth $84.2K as of Q2 2026.
Sherman Asset Management sold 1,336 Pfizer shares in Q2 2026, an estimated $34.9K.
Pfizer made up 0.07% of Sherman Asset Management's portfolio in Q2 2026, its #85 holding.
Sherman Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Sherman Asset Management's Pfizer position peaked at $136K in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.